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Abstract. 
 
N-cadherin and 
 
b
 
1-integrins play decisive 
roles in morphogenesis and neurite extension and are 
often present on the same cell. Therefore, the function 
of these two types of adhesion systems must be coordi-
nated in time and space to achieve the appropriate cell 
and tissue organization. We now show that interaction 
of the chondroitin sulfate proteoglycan neurocan with 
its GalNAcPTase receptor coordinately inhibits both
N-cadherin– and 
 
b
 
1-integrin–mediated adhesion and 
neurite outgrowth. Furthermore, the inhibitory activity 
 
is localized to an NH
 
2
 
-terminal fragment of neurocan 
containing an Ig loop and an HA-binding domain. The 
effect of neurocan on 
 
b
 
1-integrin function is dependent 
on a signal originating from the cadherin cytoplasmic 
domain, possibly mediated by the nonreceptor protein 
tyrosine kinase Fer, indicating that cadherin and inte-
grin engage in direct cross-talk. In the developing chick, 
neural retina neurocan is present in the inner plexiform 
layer from day 7 on, and the GalNAcPTase receptor be-
comes restricted to the inner nuclear layer and the gan-
glion cell layer (as well as the ﬁber layer), the two form-
ing a sandwich. These data suggest that the coordinate 
inhibition of cadherin and integrin function on interac-
tion of neurocan with its receptor may prevent cell and 
neurite migration across boundaries.
Key words: cadherin • integrin • adhesion • neurite 
outgrowth • tyrosine kinase Fer
 
Introduction
 
The characteristic cellular patterns that arise during devel-
opment are a result of complex cell and tissue rearrange-
ments. Nowhere is this complexity more apparent than in
the development of the nervous system. The number and
type of cell-surface receptors that transduce signals from
environmental cues to the cytoplasmic machinery that ulti-
mately directs growth cone guidance are extensive. Envi-
ronmental cues too come in many forms including the fol-
lowing: diffusible molecules, cell-surface molecules, and
extracellular matrix molecules. Whereas the identity of the
cell-surface receptors, their environmental triggers, and
even the nature of many of the signaling pathways has
been unfolding apace (for reviews see Goodman and Tes-
sier-Lavigne, 1997; Mueller, 1999; Song and Poo, 1999), the
machinery that integrates and coordinates the responses
to various cues within a single growth cone remains rela-
tively unknown.
 
b
 
1-Integrins and N-cadherin have long been recognized
as two transmembrane adhesion receptors critical to neu-
rite outgrowth (Bixby et al., 1988; Neugebauer et al., 1988;
Tomaselli et al., 1989). We have previously suggested
that a cell-surface glycosyltransferase (GalNAcPTase)
 
1
 
may be a critical component of one regulatory circuit that
coordinates the activity of these two adhesion systems
(Gaya-Gonzalez et al., 1991; Lilien et al., 1997, 1999). The
GalNAcPTase is anchored to the plasma membrane by a
glycophosphatidylinositide linkage (Balsamo and Lilien,
1993), and specifically associates with N- and E-cadherin
(Balsamo and Lilien, 1990; Bauer et al., 1992) but not 
 
b
 
1-
integrins (Lilien et al., 1999). Binding of one unique mAb
to the GalNAcPTase initiates a signal that results in coor-
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dinate inhibition of N-cadherin and 
 
b
 
1-integrin–mediated
neurite outgrowth (Gaya-Gonzalez et al., 1991). We hy-
pothesized that the activity of this antibody reflected the
activity of an endogenous ligand. Indeed, we subsequently
identified and purified a 250-kD chondroitin sulfate pro-
teoglycan (250kD PG) that binds to the same, or an over-
lapping, domain of the GalNAcPTase. It also initiates a
signal that results in retention of the phosphate on ty-
rosine residues of 
 
b
 
-catenin and uncoupling of cadherin
from its association with actin, with concomitant inhibition
of N-cadherin–mediated adhesion and neurite outgrowth
(Balsamo et al., 1995, 1996).
To further study the molecular mechanism of the inter-
action between 250kD PG and its receptor, GalNAcPT-
ase, we have isolated the complete cDNA coding for the
250kD PG and show that binding of the protein backbone
to the GalNAcPTase initiates a signal cascade that results
in coordinate inhibition of cadherin- and integrin-medi-
ated adhesion and neurite outgrowth. Sequence analysis
shows that the 250kD PG is the chicken homologue of
neurocan. Chicken neurocan contains the conserved NH
 
2
 
-
and COOH-terminal protein motifs characteristic of the ag-
grecan/versican/neurocan/brevican family of chondroitin
sulfate proteoglycans (Ruoslahti, 1996; Schwartz et al.,
1999). The conserved motifs are 
 
z
 
70% similar to rat neu-
rocan, but there is little sequence similarity (
 
,
 
10%) in the
central region, where the majority of the consensus sites
for attachment of chondroitin sulfate side chains occur.
The coordinate regulation of cadherin and integrin func-
tion is due to a direct interaction between the NH
 
2
 
 termi-
nus of neurocan containing the Ig loop and hyaluronic acid
(HA-binding) domain and the GalNAcPTase, as removal
of the GalNAcPTase with PI-PLC abrogates the coordi-
nate regulatory activity. Furthermore, coordinate regula-
tion appears to be due to a signal originating from the cy-
toplasmic domain of cadherin directly affecting integrin
function. Our results suggest a mechanism whereby neu-
rite outgrowth may be directionally controlled by environ-
mental cues defining axonal trajectories.
 
Materials and Methods
 
Antibodies
 
Preparation of anti-PG250 antibody (Balsamo et al., 1995) and the an-
tineurocan antibody (Zanin et al., 1999) were described previously. Anti–
N-cadherin antibody NCD-2 is a monoclonal rat IgG (the cell line was
provided by M. Takeichi, Kyoto University, Kyoto, Japan; Hatta and
Takeichi, 1986). The anti–
 
b
 
1-integrin antibody, JG22, is a mouse mono-
clonal IgG (Greve and Gottlieb, 1982; Tomaselli et al., 1986) and the anti-
FAK antibody is a monoclonal IgG (Transduction Laboratories). Anti–
 
b
 
-
catenin antibodies are a rabbit polyclonal IgG directed against a synthetic
15-amino acid sequence (Balsamo et al., 1995) and a mouse mAb (Trans-
duction Laboratories). The antiactin antibody is a monoclonal mouse IgG
(Chemicon International, Inc.). The antiphosphotyrosine antibody, PY20,
was purchased from Transduction Laboratories. Two anti-GalNAcPTase
antibodies, 1B11 and 7A2, are mouse IgMs prepared as described previ-
ously (Scott et al., 1990; Balsamo et al., 1991). Antisyntaxin antibody
HPC-1 is a mouse monoclonal IgG purchased from Sigma Chemical Co.
The following three mAbs were provided by Dr. Vance Lemmon (Case
Western Reserve University, Cleveland, OH): 8D9 (anti-chicken L1),
3G3, and 3A7. Secondary antibodies, Cy3-conjugated goat anti–mouse
IgG, FITC-conjugated donkey anti–rat IgG, FITC-conjugated goat anti–
rabbit IgG, and rhodamine-conjugated goat anti–mouse IgM were pur-
chased from Jackson ImmunoResearch Laboratories, Inc.
 
Isolation of the cDNA Encoding Neurocan
 
Total RNA was purified from day 10 embryonic chicken brain (E10) and
retina using an RNeasy kit (Qiagen). RNA was reverse transcribed into
first-strand cDNA using a degenerate primer based on the amino acid se-
quence of the most highly conserved region of the HA-binding domain
present in all members of the hyaluronic acid binding family of proteins,
CDAGWL: 5
 
9
 
-A(GA)CCAICCIGC(AG)TC(AG)CA-3
 
9
 
 (Rauch et al.,
1992). PCR was performed using two sets of nonoverlapping primers de-
rived from microsequencing of the NH
 
2
 
 terminus and a cyanogen bromide
fragment of the 250 kD PG core protein. Inosine (I) was used to reduce
degeneracy.
The NH
 
2
 
-terminal amino acid sequence with the two nested primers
underlined are as follows: DQDEGKVIHISRVQHQAVRVGLGEPV-
ALP, 5
 
9
 
-GGIAA(AG)GTIATICA(CT)ATI(AT(GC)I(AC)GIGTICA-
3
 
9
 
; and 5
 
9
 
-GTIGGI(TC)TIGGIGA(AG)CCIGTIGCI(TC)TICC-3
 
9
 
. The
internal sequence with two nested primers underlined are as follows:
DNSAVIASPQHLQ... and ...QAAFEDGYDN, 5
 
9
 
-TT(AG)TC(AG)-
TAICC(AG)TC(TC)TC(AG)AAIGCIGC(TC)TG-3
 
9
 
; and 5
 
9
 
-TGIA-
(AG)(AG)TG(TC)TGIGGI(GC)(AT)IGCIATIACIGC-3
 
9
 
.
A 450-bp product was obtained, subcloned into the TA vector (Invitro-
gen Corp.) and sequenced. This sequence showed 71% similarity to rat
and mouse neurocan. The PCR product was radiolabeled and used as a
probe to screen a chick brain 
 
l
 
-Zap cDNA library. Eight positive clones
were isolated and cloned into pBluescript SK (Stratagene). Restriction
pattern analysis revealed two distinct clones with inserts of 1.8 and 2.0 kb,
with 1.5 kb of overlap yielding 2.3 kb of unique sequence. To obtain the
full-length cDNA sequence, reverse transcriptase-inverse-PCR was used
(Zeiner and Gehring, 1994). In brief, first-strand cDNA was made from
E10 chick brain total RNA using an oligo-dT primer, followed by second-
strand cDNA synthesis and blunt-end circularization of the double-
stranded cDNA. The circularized cDNA was used as a template for a set
of nested primers based on the 5
 
9
 
 and 3
 
9
 
 ends of the 2.3 kb of known se-
quence pointing away from the known sequence, allowing amplification of
regions flanking the 2.3-kb fragment. A complete clone was constructed
by recombinant PCR using the high fidelity polymerase, elongase
(GIBCO BRL) and sequenced (sequence data available from GenBank/
EMBL/DDBJ under accession number AF116856).
 
Northern Blot Analysis
 
Total RNA was isolated from E10 chick brains using the RNeasy kit
(Qiagen). 5
 
 m
 
g of total RNA was separated on 1% denaturing agarose gel,
transferred to Hybond-N
 
1
 
 membrane (Amersham), and hybridized with a
probe of 1.1 kb from the central region of the cDNA sequence. This probe
was used as it is the least conserved region of the full-length clone. After
high stringency washes, (0.1
 
3 
 
SSPE, 0.1% SDS) the membrane was ex-
posed to Biomax X-film (Eastman Kodak Co.).
 
Preparation of Recombinant His-tagged Bacterial 
Fusion Protein
 
The complete open reading frame lacking the signal peptide (nucleotides
128–4467), with adaptor sequences, was obtained by PCR, digested with
NdeI and BglII, and ligated into pET-15b (Novagen, Inc.), which was pre-
digested with the same enzymes. Fusion protein fragments representing
the NH
 
2
 
- and COOH-terminal domains were generated as follows (see
Fig. 2). An NH
 
2
 
-terminal fragment was generated by cutting the full-
length construct with NdeI and partially with XhoI, ligating the released
DNA fragment containing nucleotides 128–1400 into the pET-15b vector
that was predigested with the same enzymes. A COOH-terminal fragment
was generated by cutting the full-length construct with BamHI and the re-
leased DNA fragment, containing nucleotides 2668–4467, was ligated into
BamHI-linearized pET-15b vector. The NH
 
2
 
-terminal construct was fur-
ther cut with XhoI to generate an Ig (nucleotides 128–518) and an HA
(nucleotides 518–1400) fragment. A second Ig fragment containing a piece
of HA-binding region was generated by PCR using the 5
 
9
 
 primer used to
clone the complete open reading frame and a 3
 
9
 
 primer corresponding to
nucleotides 599–622. All fragments were also ligated into pET-15b at ap-
propriate restriction sites and confirmed by sequencing. The constructs
were transformed into BL21(DE) (Novagen, Inc.), and induced bacteria
were pelleted and stored at 
 
2
 
80
 
8
 
C until needed. Fusion proteins were ex-
tracted from the cell pellet in buffer containing 6 M urea, purified on Ni
 
2
 
1
 
columns following the manufacturer’s recommendations (Novagen, Inc.),
and renatured by a series of dialyses in PBS with 0.1 mM DTT. The final
products were aliquoted and frozen at 
 
2
 
80
 
8
 
C. 
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Single Cell Preparation and Adhesion Assays
 
For N-cadherin–mediated adhesion, E9 chick neural retina single cells
were prepared by trypsinization of tissues in the presence of 1 mM Ca
 
2
 
1
 
 as
previously described (Balsamo et al., 1995) with minor modifications. Sin-
gle cells were washed 2
 
3
 
 in HBSGKCa (20 mM Hepes, pH 7.4, 150 mM
NaCl, 2 mM glucose, 3 mM KCl, and 1 mM CaCl
 
2
 
) and resuspended in
HBSGKCa at 2 
 
3
 
 10
 
7
 
 cells/ml. For integrin-mediated adhesion, E9 chick
neural retina cells were prepared as above; however, calcium was omitted
and trypsinization was performed for 10 min in contrast to the usual 30
min. The cells were preincubated on ice for 15 min with or without addi-
tives and 100-
 
m
 
l aliquots containing 10
 
5
 
 cells were added to each well of a
96-well plate previously coated with N-cadherin or laminin. Glass cover-
slips were coated with 250 
 
m
 
g/ml poly-
 
L
 
-lysine (Sigma Chemical Co.) at
37
 
8
 
C for 2 h, washed with water, and postcoated with NCD-2 or laminin as
described previously (Arregui et al., 1999). The coverslips were subse-
quently blocked with 1% BSA in HBSGK for a minimum of 2 h at room
temperature. E7 chick neural retina cells (10
 
5
 
 cells/ml), prepared by
trypsinization in the absence of Ca
 
2
 
1
 
, were plated on each coverslip in F12
medium (GIBCO BRL) including 1% ITS (insulin/transferin/selenium;
GIBCO BRL), 2% glucose, and 0.5% gentamycin (Sigma Chemical Co.)
as previously described (Gaya-Gonzalez et al., 1991). After 2 h in culture,
and thereafter every 3 h, neurocan peptides were added to the culture me-
dium. After 12 h, cells were fixed with 4% paraformaldehyde in PBS for
30 min at room temperature and images captured with a SenSys CCD
camera (Photometrics) and analyzed with a Metamorph image analysis
system. Cells bearing neurites longer than one cell diameter were consid-
ered positive for neurite extension.
 
Interaction of Neurocan with the
Cell-surface GalNAcPTase
 
E9 retina cells, prepared by trypsinization in the presence of Ca
 
2
 
1
 
 as de-
scribed above, were incubated with neurocan fusion peptides (
 
z
 
20
 
 3 
 
10
 
6
 
cells/100 
 
m
 
l of HBSGKCa containing 
 
z
 
0.2 mM fusion peptide or BSA)
for 1 h at 4
 
8
 
C. Cells were pelleted, resuspended in 0.25 mM DTSSP cross-
linker (Pierce Chemical Co.) in PBS, and incubated at 4
 
8
 
C for 30 min. The
cells were again pelleted, washed in HBSGKCa, and lysed in homogeniza-
tion buffer (1% Triton X-100, 20 mM Tris, pH 7.5, 150 mM NaCl, 1:1,000
AESBF [Sigma Chemical Co.], 100 
 
m
 
g/ml DNase, 2 mM 
 
o
 
-vanadate, 1 mM
NaF) at 4
 
8
 
C for 30 min. The lysates were centrifuged at 14,000 
 
g
 
 for 5 min,
and the supernatant was mixed with an equal volume of Immunomix (1%
Triton X-100, 0.5% DOC, 1% SDS, 0.1% BSA in 25 mM Tris, pH 7.9, 150
mM NaCl, 1 mM PMSF). The solution was cleared by centrifugation and
incubated with monoclonal anti-GalNAcPTase antibody for 2 h at 4
 
8
 
C.
The precipitates were collected using goat anti–mouse IgM attached to
magnetic beads, washed in Immunomix, and fractionated by SDS-PAGE.
Western transfers were probed with polyclonal antineurocan antibody or
HRP nickel (KPL) as previously described (Balsamo et al., 1995). As con-
trols, peptides were added to cells immediately after treatment with the
cross-linking reagent.
 
Association of N-Cadherin with the Actin Cytoskeleton
 
Coprecipitation of N-cadherin and actin was carried out as previously de-
scribed (Balsamo et al., 1991) with minor modifications. 10
 
5
 
 E9 chick ret-
ina cells (see above) were preincubated with or without neurocan peptides
for 5 or 15 min on ice, in a total volume of 0.5 ml, followed by 5 min at
37
 
8
 
C and 120 rpm. The cells were pelleted and lysed on ice in 1 ml of ho-
mogenization buffer for 30 min. The lysates were centrifuged at 14,000 
 
g
 
for 5 min, and the supernatants were incubated with anti–N-cadherin anti-
body NCD-2 (5 
 
m
 
g/ml) under constant rotation at 4
 
8
 
C for 4 h. The samples
were incubated for an additional 1 h with goat anti–rat IgG-conjugated
magnetic beads (PerSeptive Biosystems), washed four times in homogeni-
zation buffer, boiled in 50 
 
m
 
l of SDS sample buffer for 5 min, fractionated
by SDS-PAGE, and Western transfers were probed with antiactin anti-
body and the anti–N-cadherin antibody NCD-2 as described previously
(Balsamo et al., 1995).
 
Tyrosine Phosphorylation of 
 
b
 
-Catenin
 
Cells were treated as above for coprecipitation of actin and N-cadherin,
with the exception that all cell homogenates were made 1% in SDS to dis-
rupt protein–protein interactions. The cell lysate was diluted to 0.1% SDS
with homogenization buffer, and immunoprecipitated with anti–
 
b
 
-catenin
antiserum (1:100). The immunoprecipitates were fractionated by SDS-
PAGE and Western transfers were probed with antiphosphotyrosine anti-
body (PY 20; Transduction Laboratories), followed by HRP-conjugated
goat anti–mouse IgG. The membranes were stripped and reprobed with
anti–
 
b
 
-catenin antibody (Transduction Laboratories) and developed with
alkaline phosphatase–conjugated goat anti–rabbit IgG (Jackson Immu-
noResearch Laboratories, Inc.).
 
Cell Permeable Peptides
 
Peptides containing the cell permeable sequence derived from the anten-
napedia homeodomain (Perez et al., 1992; Derossi et al., 1994; Prochiantz,
1996) and sequences from the N-cadherin cytoplasmic domain (Arregui et
al., 2000) were synthesized and purified to 
 
.
 
90% by HPLC (Genemed
Biotechnologies, Inc.). All peptides were dissolved in sterile deionized
water, stored in small aliquots at 
 
2
 
70
 
8
 
C, and used at 2 
 
m
 
M, a concentra-
tion that gives maximal inhibition without toxicity (Arregui et al., 2000).
The three peptides used are as follows: COP, RQIKIWFQNRRMKWKK
(antennapedia sequence alone); CBP, RQIKIWFQNRRMKWKKSLL-
VFDYEGSGSTAGSLSSL (antennapedia plus the 
 
b
 
-catenin binding re-
gion); and JMP, RQIKIWFQNRRMKWKKRQAKQLLIDPEDDVRD-
NILK (antennapedia plus the juxtamembrane region).
 
Immunohistochemistry
 
Chicken eyes from embryos at different ages were carefully dissected in
cold PBS, and fixed in freshly made 4% paraformaldehyde at 4
 
8
 
C over-
night. Fixed eyes were washed three times in PBS (10–15 min each), and
the neural retina and pigmented retina layers were removed and main-
tained in 30% sucrose in PBS overnight at 4
 
8
 
C and frozen in Histoprep
medium (Fisher Scientific) at 
 
2
 
80
 
8
 
C. 20-
 
m
 
m sections were cut at 
 
2
 
25
 
8
 
C,
picked up on gelatin-coated coverslips, air-dried on a 37
 
8
 
C hot plate, and
frozen at 
 
2
 
20
 
8
 
C. Before staining, the sections were heated to 60
 
8
 
C on a
hot plate, rehydrated, and washed three times with PBS. After blocking
with 3% goat serum in PBS for 2 h at room temperature, the sections were
incubated with the appropriate primary antibody in 3% goat serum in
PBS at room temperature for 1 h. After washing three times with PBS, the
sections were incubated with secondary antibody in 3% goat serum in
PBS at room temperature for 1 h, followed by another three washes with
PBS. Finally, the sections were mounted on slides with Vectashield (Vec-
tor Laboratories, Inc.) antifading mounting medium, sealed with nail pol-
ish, and analyzed as for neurite outgrowth.
Single cells were prepared and plated on laminin-coated coverslips as
described above for neurite outgrowth assays at a density of 100,000 cells/
coverslip. The cells were cultured overnight, and fixed in 4% paraformal-
dehyde for 20 min at room temperature. For immunostaining, cells were
treated similarly to tissue sections, except that 0.4% saponin was included
in the incubation buffer when cell permeabilization was required. Tissue
sections and cells were observed under phase and epifluorescence using a
Zeiss universal microscope. Images were captured and analyzed as for
neurite outgrowth.
 
Results
 
The 250kD PG cDNA Encodes the Chicken Homologue 
of Neurocan
 
The complete cDNA clone has an open reading frame of
3,861 bp, encoding 1,287 amino acids with a calculated
molecular mass of 141.6 kD. This is flanked by 65 bp of 5
 
9
 
-
untranslated region, 705 bp of 3
 
9
 
-untranslated region in-
cluding a polyadenylation signal, AATAAA, and the
poly-A tail. Database searches at both the nucleic acid and
deduced amino acid levels indicate that the cDNA en-
codes the chicken homologue of neurocan (Fig. 1). All
four neurocans thus far sequenced (rat [Rauch et al.,
1992], mouse [Rauch et al., 1995], human [Prange et al.,
1998], and chick) are organized similarly: the NH
 
2
 
 termi-
nus contains an Ig-like domain, followed by the hyaluronic
acid binding domain, a central region rich in proline, and
the COOH terminus with two EGF-like repeats, a lectin-
like domain, and a complement regulatory-like domain 
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(Fig. 2). The NH
 
2
 
- and COOH-terminal regions have 
 
z
 
70%
sequence identity between chicken and rat, whereas the
central region shows little similarity, 
 
,
 
10%.
Analysis of the deduced amino acid sequence indicates
the presence of four NXS/T consensus sequences for po-
tential N-glycosylation (Bause, 1983) and six potential
GAG attachment sites based on the presence of an SG
dipeptide, closely preceded by an acidic amino acid, or fol-
lowed by XG, where X is any amino acid (Bourdon et al.,
1987; Kreuger et al., 1990). Two RGD sequences are also
present in the central region of chick neurocan (Fig. 2),
whereas the rat has only one (Rauch et al., 1992, 1995),
which is not at the same position as either in the chicken,
but none appear in the mouse or human homologues. In
addition, the COOH terminus contains a stretch of histi-
dine residues (1,251–1,266; Fig. 1). The entire neurocan
molecule appears as two globular domains separated by an
extended linear region, composed of the unique central
domain that bears all of the chondroitin sulfate side chains
(Retzler et al., 1996b). Except for the HA-binding domain,
little is known about the physiological or developmental
functions of these domains.
Northern analysis with total RNA from E10 chicken
brain reveals a single band of 
 
z
 
5.4 kb (not shown). This is
significantly smaller than the rat or human mRNA (Rauch
et al., 1992; Prange et al., 1998). Given the conserved size
of the coding region, this discrepancy in message size is
most likely because of the differences in the 3
 
9
 
 and/or 5
 
9
 
noncoding regions.
To determine whether the cloned cDNA represented
the 250kD PG, recombinant neurocan produced in bacte-
ria was reacted with anti-250kD PG antibody (Fig. 3).
Neurocan is recognized by affinity-purified anti-250kD
PG antibody. Additional bands recognized by the anti-
250kD antibody are most likely degradation products. The
recombinant polypeptide has a calculated molecular mass
Figure 1. Sequence compari-
son between the four cloned
neurocans: chicken, human,
mouse, and rat. Shaded areas
represent identical amino ac-
ids, and boxed areas repre-
sent conservative changes. 
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of 141.6 kD, however, the apparent molecular mass on
SDS-PAGE is 
 
.
 
200 kD. This discrepancy in migration
rate was also seen when recombinant rat neurocan was
fractionated by SDS-PAGE. This has been attributed to
the stiff, rodlike structure of the central region of the mol-
ecule (Retzler et al., 1996b).
 
Recombinant Neurocan and Its NH
 
2
 
-terminal 
Fragment Inhibit N–Cadherin-mediated Adhesion and 
Neurite Outgrowth
 
The neurocan polypeptide backbone was expressed as a
His-tagged fusion protein, purified on a Ni
 
2
 
1
 
 column, and
assayed for its effect on cadherin-mediated adhesion and
neurite outgrowth. Full-length neurocan fusion protein
(RP) at 20 
 
m
 
g/ml inhibits N–cadherin-mediated cell adhe-
sion by 60% (Fig. 4 A). This indicates that the polypeptide
backbone of neurocan is sufficient for inhibition, and that
the sugar chains on tissue-derived neurocan core protein
are unlikely to be contributing to the inhibitory effect.
That the assay reflects N–cadherin-mediated adhesion is
seen by the ability of the anti–N-cadherin antibody NCD-2
to completely block adhesion (Fig. 4 A). The anti-Gal-
NAcPTase antibody 1B11 also functionally blocks N–cad-
herin-mediated adhesion on binding to the cell-surface
GalNAcPTase, in agreement with our previous observa-
tions (Balsamo et al., 1991).
To define the specific domain of neurocan that is re-
sponsible for inhibition of cadherin-mediated adhesion,
we prepared His-tagged fusion fragments of neurocan rep-
resenting the NH
 
2
 
 terminus (RN), containing the Ig-loop
and the HA-binding domain, and the COOH terminus
(RC), containing the EGF-like repeats, the lectinlike do-
main, and the complement regulatory-like domain (Fig. 2
B). Treatment of retina cells with the NH
 
2
 
-terminal frag-
ment, but not the COOH-terminal fragment, results in in-
hibition of cadherin-mediated adhesion by 
 
.
 
90% at 10
 
m
 
g/ml (Fig. 4 A, RN versus RC). Inhibition by the NH
 
2
 
-
terminal fragment is dose-dependent exhibiting half maxi-
mal inhibition at 
 
,
 
5 
 
m
 
g/ml (Fig. 4 B). The fact that the
NH
 
2
 
-terminal fragment is more active than the full-length
protein may be accounted for by the difficulty of maintain-
ing the full-length protein in a soluble state, possibly be-
cause of aggregation. In an attempt to further define the
active domain, His-tagged fusion fragments containing the
Ig loop alone (Fig. 2 B, Ig1), the Ig loop with a fragment of
the HA domain (Fig. 2 B, Ig2) and the HA domain were
also assayed. None of these additional fragments are ac-
tive, nor is simultaneous addition of separate fusion frag-
ments representing the Ig loop and the HA domain (not
shown). This indicates that the Ig loop and the HA do-
main must be contiguous, possibly to maintain a specific
configuration.
To further characterize the inhibitory effect of recombi-
nant neurocan and its fragments, we assayed their effect
on N–cadherin-mediated neurite outgrowth by E7 retina
cells. The results are in agreement with those for adhesion.
The NH
 
2
 
-terminal fragment of neurocan, but not the
COOH-terminal fragment inhibits neurite extension (Fig.
5, A and B). As for adhesion, inhibition of neurite out-
growth by the anticadherin antibody NCD-2 as well as the
Figure 2. (A) Diagram of chick neurocan showing its multiple
domains and (B) the regions expressed as fusion peptides. N indi-
cates the position of potential N-linked oligosaccharides, and cs
indicates potential chondroitin sulfate attachment sites. RGD in-
dicates the presence of the consensus integrin-binding sequence
(Arg-Gly-Asp). SP refers to the signal peptide and CRL to com-
plement regulatory-like domain. Small numbers refer to residue
number.
Figure 3. Recombinant chick
neurocan is recognized by
anti-250kD PG antibody. Ly-
sates of bacteria trans-
formed with plasmids con-
taining the complete chick
neurocan cDNA were frac-
tionated by SDS-PAGE and
stained with Coomassie bril-
liant blue (CBB), or trans-
ferred to polyvinylidene di-
fluoride membranes and
immunoblotted with anti-250kD PG antibody. U, lysate from
noninduced bacteria; and I, lysate from bacteria induced with
IPTG. Numbers to the left refer to the migration of molecular
mass markers (1023).
Figure 4. Recombinant neu-
rocan and its NH2-terminal
fragment inhibit N-cadherin–
mediated adhesion. Single
cells were prepared from E9
retinas and added to 96-well
plates coated with anti–N-cad-
herin antibody at 378C for 30
min in the presence of the in-
dicated additives. The plates
were washed and adherent
cells determined by staining
with crystal violet. Adhesion
in the absence of any addi-
tives was considered 100%.
(A) Co, no additives; 1B11,
anti-GalNAcPTase antibody;
NCD, anti–N-cadherin anti-
body; RP, full-length recom-
binant neurocan; RN, NH2-
terminal fragment; and RC,
COOH-terminal fragment.
(B) Adhesion in the presence
of increasing concentrations
of RN and RC.The Journal of Cell Biology, Volume 149, 2000 1280
anti-GalNAcPTase mAb 1B1 indicate that neurite out-
growth is mediated by N-cadherin. Importantly, neurite
outgrowth on poly-L-lysine is unaffected by neurocan (not
shown). Thus, it is specifically the function of cadherin (or
integrin, see below) that is affected, not other aspects of
the machinery required for neurite outgrowth.
The NH2-terminal Fragment of Neurocan Inhibits
b1-Integrin–mediated Adhesion and Neurite Outgrowth
We have previously demonstrated that binding of the anti-
GalNAcPTase antibody 1B11 to chick retina cells results
in inhibition of both cadherin- and integrin-mediated ad-
hesion (Gaya-Gonzalez et al., 1991), and our working hy-
pothesis is that neurocan is an endogenous ligand for the
cell-surface GalNAcPTase (Balsamo et al., 1995). This led
us to determine if the NH2-terminal fragment of neurocan
is also active in inhibiting b1-integrin–mediated adhesion
and neurite outgrowth. E8 chick retina cells were assayed
for adhesion to laminin-coated wells in the presence and
absence of the NH2-terminal neurocan fragment. The
anti–chick  b1 antibody JG22 (Greve and Gottlieb, 1982;
Tomaselli et al., 1986; Gaya-Gonzalez et al., 1991), and the
anti–N-cadherin antibody NCD-2 serve as controls for the
extent and specificity of adhesion. NCD-2 has no effect on
adhesion to laminin, whereas JG22 maximally inhibits ad-
hesion by z60% (Fig. 6). This residual adhesion may be a
result of nonspecific interactions or the function of non-
integrin laminin receptors (Powell and Kleinman, 1997).
Like JG22, the NH2-terminal fragment inhibits adhesion
to laminin by z60% at 10 mg/ml, whereas the COOH-ter-
minal fragment has little or no effect (Fig. 6). This suggests
that the NH2-terminal fragment inhibits b1-integrin–medi-
ated adhesion by close to 100%. b1-Integrin–mediated
neurite outgrowth is similarly affected; the NH2-terminal,
but not the COOH-terminal fragment, inhibits neurite ex-
tension (Fig. 7 A) with maximal inhibition by the NH2-ter-
minal fragment of z60% at 10 mg/ml (Fig. 7 B). In agree-
ment with our previous observations (Gaya-Gonzalez et
al., 1991), the anti-GalNAcPTase antibody 1B11 inhibits
neurite extension on laminin. Thus, interaction of the
NH2-terminal fragment of neurocan with cells results in
coordinate inhibition of cadherin- and integrin-mediated
adhesion and neurite outgrowth.
Neurocan-mediated Inhibition of Cadherin and Integrin 
Function Is via the GalNAcPTase
Native neurocan core protein binds to the glycophosphati-
dylinositol-linked cell-surface GalNAcPTase (Balsamo et
al., 1995). To determine if recombinant neurocan and its
NH2-terminal fragment also bind directly to the Gal-
NAcPTase, cells were incubated with the full-length neu-
rocan, the NH2- and COOH-terminal fragments, followed
by the reducible cross-linking reagent DTSSP. After lysis
and precipitation with anti-GalNAcPTase antibody, West-
ern transfers of SDS-PAGE were probed with antineuro-
can antibody that recognizes both fragments. Full-length
neurocan and the NH2-terminal fragment, but not the
COOH-terminal fragment, are present (Fig. 8), indicating
that neurocan interacts with the GalNAcPTase through
the NH2 terminus.
The GalNAcPTase is associated with the cell surface
through a glycophosphatidylinositide linkage (Balsamo
and Lilien, 1993). Removal of the GalNAcPTase by treat-
ing cells with PI-PLC eliminates the effect of the 250kD
PG/neurocan on cadherin-mediated adhesion and neurite
Figure 5. The NH2-terminal fragment of neurocan inhibits
N-cadherin–mediated neurite outgrowth. E7 retina cells were
plated on anti–N-cadherin–coated coverslips and incubated for
2 h before addition of anti–N-cadherin antibodies (NCD), neuro-
can NH2-terminal fragment (RN) or COOH-terminal fragment
(RC). RN and RC were added to the cultures three more times,
after 3-h intervals. The cells were fixed and observed under a mi-
croscope. (A) Representative fields of each treatment (RN and
RC at 10 mg/ml). (B) The number of cells bearing neurites longer
than one cell diameter is expressed as a percentage of the control
(number of cells bearing neurites in the absence of additives: 59 6
7; n 5 100). 1B11, anti-GalNacPTase antibody. RN and RC were
assayed at 10, 25, and 50 mg/ml.
Figure 6. The NH2-terminal
fragment of neurocan inhibits
b1-integrin–mediated adhe-
sion. Single cells from E9 ret-
ina were plated on laminin-
coated 96-well plates and
incubated in the presence of
the designated additives. Co,
no additives; JG22, anti–
b1-integrin antibody; NCD,
anti–N-cadherin antibody; RN
and RC, neurocan NH2- and
COOH-terminal fragments respectively at 10 mg/ml. Adhesion
was measured as percent of control.Li et al. Coordinate Regulation of Cadherin and Integrin by Neurocan 1281
outgrowth (Balsamo et al., 1995). Similarly, treatment
of E9 chick retina cells with PI-PLC removes the
GalNAcPTase (Fig. 9, box at top) and eliminates the ef-
fect of neurocan on b1-integrin–mediated neurite out-
growth (Fig. 9).
We previously suggested that the inhibitory effect of the
250kD PG/neurocan on cadherin function was due to a
signal initiated on binding to the GalNAcPTase that re-
sults in retention of phosphate on tyrosine residues of
b-catenin with concomitant uncoupling of N-cadherin
from the actin-containing cytoskeleton (Balsamo et al.,
1995). Similarly, treatment of E9 chick retina cells with
recombinant neurocan or its NH2-terminal fragment, but
not the COOH-terminal fragment, reduces the amount of
actin associated with N-cadherin and increases the phos-
photyrosine content of b-catenin. Disruption of the cad-
herin/actin connection and enhancement of the phospho-
tyrosine content of b-catenin is very rapid, occurring
within 5 min after incubation of cells with neurocan and
remaining relatively constant through 15 min (Fig. 10). In
contrast to the pattern of b-catenin phosphorylation, dis-
assembly of the cadherin–cytoskeletal connection, as mea-
sured by coimmunoprecipitation of actin, increases during
the first 15 min of incubation with neurocan (Fig. 10, top).
The Effect of Neurocan on Integrin-mediated Adhesion 
Is Mediated by N-Cadherin
Neurocan binds to the GalNAcPTase through its NH2 ter-
minus, initiating a signal that results in the inhibition of
Figure 7. The NH2-terminal fragment of neurocan inhibits b1-
integrin–mediated neurite outgrowth. E7 retina cells were plated
on laminin-coated glass coverslips and incubated for 2 h before
the addition of anti-integrin antibody JG22, RN, or RC, as de-
scribed in Fig. 5. (A) Representative fields of each treatment
(RN and RC at 20 mg/ml). (B) The number of cells bearing neu-
rites longer than one cell in diameter is expressed as a percentage
of the control. 1B11, anti-GalNacPTase antibody; JG22, anti–
b1-integrin antibody. RN and RC were assayed at 10 and 25 mg/ml.
Figure 8. Neurocan and its
NH2-terminal fragment bind
to the cell-surface Gal-
NAcPTase. Single cells pre-
pared from E9 retinas were
incubated with no additives
(CO), RN (20 mg/ml), RC
(20  mg/ml), or RP (40 mg/ml)
for 30 min at 378C. The cells
were treated with the cross-
linking reagent DTSSP. Tri-
ton X-100 lysates of cells
were immunoprecipitated
with anti-GalNAcPTase anti-
body, fractionated by SDS-
PAGE, and Western transfers were prepared. RN/0, cross-linking
and lysis at 0 time. (top) Immunoblot with antineurocan anti-
body. (bottom) Immunoblot with anti-GalNAcPTase antibody.
Figure 9. Removal of cell-
surface GalNAcPTase with
PIPLC eliminates the effect
of the neurocan NH2-termi-
nal fragment on integrin-me-
diated neurite outgrowth. E7
retina cells were incubated
with or without 5u/ml PIPLC
for 30 min at 308C. The cells
were assayed for neurite
growth, as described Fig. 7,
and for the presence of the
GalNAcPTase by immuno-
blot after SDS-PAGE, West-
ern transfer, and immunoblot
(top).
Figure 10. Treatment of cells
with neurocan NH2-terminal
fragment results in dissocia-
tion of N-cadherin from actin
and hyperphosphorylation of
b-catenin on tyrosine resi-
dues. E9 retina cells were in-
cubated with RN or RC at
378C for 5 and 15 min. The
treated cells were lysed in
Triton X-100 and immuno-
precipitated with anti–N-cad-
herin antibody NCD-2. The
precipitates were fractionated by SDS-PAGE, and Western
transfers were prepared and immunoblotted with antiactin anti-
body and NCD-2 (top). The resulting supernatants were immu-
noprecipitated with anti–b-catenin antibody (after treatment
with 1% SDS to disrupt protein–protein interactions), fraction-
ated by SDS-PAGE, and immunoblotted with anti-PY antibody.
The membranes were stripped and reprobed with anti–b-catenin
antibody (bottom). The heavy bands in the top panel marked by
an asterisk are IgG heavy chains.The Journal of Cell Biology, Volume 149, 2000 1282
N-cadherin– and integrin-mediated adhesion. The signal
initiated on binding of neurocan to the GalNAcPTase re-
sults in disassembly of the complex of proteins associated
with the cytoplasmic domain of N-cadherin (see also Bal-
samo et al., 1991, 1995). Further, the GalNAcPTase is inti-
mately associated with N-cadherin (Balsamo and Lilien,
1990), but no association with integrin has been detected
(Lilien et al., 1999). Based on these data, we speculated
that one or more of the protein effectors, originally associ-
ated with the cytoplasmic domain of N-cadherin, may be
translocated to the integrin complex where it has an inhib-
itory effect on integrin-mediated adhesion and neurite
outgrowth.
In the companion paper (Arregui et al., 2000), we have
used cell permeable peptides coupled to sequences mim-
icking specific regions of the cytoplasmic domain of N-cad-
herin to cause the release of effectors from the cadherin
complex, and have assayed their effect on N-cadherin and
b1-integrin–mediated adhesion. Consistent with the above
hypothesis, a cell permeable peptide bearing a sequence
mimicking the juxtamembrane region of N-cadherin (JMP)
causes the specific release of the nonreceptor tyrosine ki-
nase Fer, normally associated with the cadherin complex
of cytoplasmic proteins (Kim and Wong, 1995; Rosato et
al., 1998), and its translocation to the cytoplasmic complex
of proteins associated with b1-integrin with concomitant
loss of b1-integrin–mediated adhesion (Arregui et al.,
2000). In contrast, treatment of cells with a cell permeable
peptide containing a sequence that mimics the b-catenin
binding region of N-cadherin (CBP) also causes the
release of Fer, but in a complex with b-catenin and
p120CAT. Under these circumstances Fer is not translo-
cated to the integrin complex and there is no effect on in-
tegrin function (Arregui et al., 2000).
To determine if treatment of cells with recombinant
neurocan NH2-terminal fragment also results in transloca-
tion of Fer from cadherin to the b1-integrin complex, ret-
ina cells were treated with recombinant NH2-terminal neu-
rocan, cell lysates immunoprecipitated with anti–N-cadherin
antibody or anti-FAK antibody, and the immunoprecipi-
tates were analyzed for the presence of Fer. Indeed, Fer is
lost from the cadherin complex and appears associated
with the integrin complex (Fig. 11). Like neurocan, treat-
ment of cells with the anti-GalNAcPTase antibody 1B11,
but not 7A2, also results in the loss of N-cadherin and b1-
integrin functions and translocation of Fer to the integrin
complex (Fig. 11). If translocation of Fer from cadherin to
integrin, on treatment of cells with neurocan, is causally
related to the loss of integrin function, we speculated that
the release of Fer complexed with p120CAT and b-cate-
nin, as occurs when cells are treated with CBP, might elim-
inate this signal, abolishing the effect of neurocan on inte-
grin-mediated adhesion. To test this idea, we pretreated
retina cells for 2 h with CBP, before addition of neurocan.
Pretreatment with CBP does in fact abolish the effect of
neurocan on b1-integrin–mediated adhesion (Fig. 12).
Treatment with the CBP alone or control antennapedia
peptide (COP) alone has no effect on integrin-mediated
adhesion (Fig. 12). Thus, a specific configuration of pro-
teins associated with the cytoplasmic domain of N-cad-
herin is essential for neurocan-mediated inhibition of
integrin function. Furthermore, translocation of the non-
receptor protein tyrosine kinase Fer from cadherin to inte-
grin appears to be at least one component of a mechanism
required for signaling from cadherin to integrin (Arregui
et al., 2000).
Neurocan and Its Receptor GalNAcPTase Have a 
Complementary Distribution in the Retina
By affecting both cadherin- and integrin-mediated adhe-
sion and neurite outgrowth, interaction of neurocan with
its receptor GalNAcPTase may have profound effects on
morphogenesis. To locate regions of the developing neural
retina where such interactions might take place, we im-
munostained retina sections from E7 to E18 with affinity-
purified polyclonal antineurocan antibody and anti-Gal-
NAcPTase antibody. By E7, neurocan is expressed in the
developing inner plexiform layer (IPL) and continues to
be associated with this layer through E18 (Fig. 13) until
hatching, when little or no staining is seen (data not shown).
Neurocan expression also appears transiently in the nerve
fiber layer and the outer plexiform layer between E15
and E18 (Fig. 13). The GalNAcPTase is initially present
throughout the retina at E7 (not shown), but becomes pro-
gressively concentrated in the ganglion cell layer, the inner
nuclear layer, and the nerve fiber layer from about E15
(Fig. 13). This is consistent with previous observations
made using other anti-GalNAcPTase antibodies (Balsamo
Figure 11. Treatment of cells with the neurocan NH2-terminal
fragment results in release of the protein tyrosine kinase Fer
from the cadherin-associated complex of proteins and its associa-
tion with the b1-integrin complex. E9 retina cells were treated
with 10 mg/ml of recombinant neurocan NH2-terminal fragment
(RN) or with anti-GalNAcPTase antibodies 1B11 or 7A2. The
cells were lysed in buffer containing nonionic detergent and the
lysates were immunoprecipitated with anti-FAK or anti–N-cad-
herin antibodies. The immunocomplexes were subjected to SDS-
PAGE, followed by immunoblotting with the indicated anti-
bodies.
Figure 12. The inhibitory ef-
fect of neurocan NH2-termi-
nal fragment on integrin-
mediated adhesion is medi-
ated through N-cadherin. E9
retina cells were incubated
with 4 mM cell permeable
control (COP) or b-catenin–
binding (CBP) peptides for
2 h at 48C. The cells were
plated on laminin-coated
dishes in the presence or ab-
sence of RN (10 mg/ml) and
incubated for 2 h at 378C. Adhesion is expressed as a percentage
of the control. COP/N and CBP/N refer to addition of peptide
followed by RN.Li et al. Coordinate Regulation of Cadherin and Integrin by Neurocan 1283
et al., 1986). Thus, during development, neurocan staining
in IPL is sandwiched by the GalNAcPTase expression in
the ganglion cell and inner nuclear layers. This is most
clearly seen in the overlay images (Fig. 13, bottom).
To identify the cell type(s) expressing neurocan and the
GalNAcPTase, E9 retina cells cultured on laminin-coated
substrates were stained with antineurocan or anti-Gal-
NAcPTase antibodies. At this time, neurocan is already
associated with the IPL, whereas the GalNAcPTase is still
very generally distributed throughout the retina. Consis-
tent with the tissue distribution, the GalNAcPTase is asso-
ciated with the vast majority of cells in culture (not
shown), whereas neurocan is strongly present on a minor-
ity population of cells with multiple processes (Fig. 14 A).
Among this population, neurocan is most strongly associ-
ated with these processes (Fig. 14), but also appears to be
secreted and bound to the surrounding substrate in some
cases (Figs. 14 and 15).
To further define the cell type on which neurocan ap-
pears, a series of antibodies recognizing proteins associ-
ated with specific cell types were used in combination with
antineurocan antibody. Consistent with the presence of
neurocan in the IPL, a marker for amacrine cells, antisyn-
taxin antibody (HPC-1; Barnstable et al., 1985), labels the
same population of cells as antineurocan (Fig. 14 B). Cells
that bind antineurocan antibody also express neurocan
mRNA, which is concentrated in the cell bodies (not
shown). Neither a bipolar cell-specific antibody 3G3 (Bur-
den-Gulley and Brady-Kalnay, 1999; Lemmon, V., per-
sonal communication), or a glial cell marker, 3A7 (Lemmon,
1985) recognize this population (not shown). Consistent
with the morphological characteristics of the neurocan-
positive cells, cells with one, unidirectional, long neurite,
which are reactive with the ganglion cell-specific antibody,
8D9 (Lemmon and McLoon, 1986), do not react with an-
tineurocan antibody (Fig. 15). However, there is a popula-
tion of cells with short, multiple neurites that are reactive
with both 8D9 and antineurocan (Fig. 15).
Discussion
Coordinate Regulation of Cadherin and Integrin
We have isolated the complete cDNA for chicken neuro-
can, and demonstrate that recombinant fusion protein,
like the purified native proteoglycan, is active in inhibiting
both N-cadherin– and b1-integrin–mediated cell adhesion
and neurite outgrowth. Coordinate regulation appears to
be mediated through the interaction of neurocan with its
receptor GalNAcPTase. Native neurocan (Balsamo et al.,
1995) and recombinant protein, as well as the smallest ac-
tive fragment, the NH2 terminus containing the Ig loop
and the HA-binding domain, all bind to the cell-surface
GalNAcPTase. Furthermore, removal of the GalNAcPT-
ase with PI-PLC abolishes the inhibitory effect on both ad-
hesion systems. Further dissection of the NH2 terminus
into the Ig loop alone, the HA domain alone, or the Ig
loop with a fragment of the HA binding results in a loss of
activity. The requirement for the HA binding domain is
consistent with our previous observation that aggregates
containing the 250kD PG with HA are inactive (Balsamo
et al., 1995); both sets of data suggest that the exposed
HA-binding domain is essential for functional interaction
with the GalNAcPTase.
In Fig. 16, we have attempted to pictorially represent
the interactions taking place on binding of neurocan to its
GalNAcPTase receptor. Loss of cadherin function is
correlated with uncoupling from the cytoskeleton after hy-
perphosphorylation and release of b-catenin from its asso-
ciation with cadherin (Balsamo et al., 1995). Hyperphos-
phorylation of b-catenin has consistently been correlated
with the loss of adhesive function (Daniel and Reynolds,
1997; Lilien et al., 1997). Our laboratory has demonstrated
that the nonreceptor protein tyrosine phosphatase PTP1B
regulates b-catenin phosphorylation (Balsamo et al., 1995,
Figure 13. Expression of neurocan and its receptor Gal-
NAcPTase in the developing retina. Frozen sections of retina
tissue at several developmental stages were stained with an-
tineurocan and anti-GalNAcPTase antibody, followed by fluo-
rescence-conjugated secondary antibodies. PH, photoreceptor
layer; OPL, outer plexiform layer; INL, inner nuclear layer; IPL,
inner plexiform layer; GCL, ganglion cell layer; and NFL, nu-
clear fiber layer.The Journal of Cell Biology, Volume 149, 2000 1284
1996, 1998). PTP1B binds to the cytoplasmic domain of
N-cadherin and is essential for the continued removal of
phosphate from tyrosine residues of b-catenin (Balsamo et
al., 1998). Furthermore, phosphorylation of PTP1B is es-
sential for binding to cadherin (Balsamo et al., 1996, 1998).
Neurocan–GalNAcPTase interaction results in inactiva-
tion or loss of protein tyrosine kinase activity from the
cadherin complex. This appears to initiate a cascade re-
sulting in the loss of PTP1B, retention of phosphate
groups on tyrosine residues of b-catenin and uncoupling of
cadherin from the actin cytoskeleton (Balsamo et al., 1995,
1996, 1998). Based on the data presented in this paper and
Arregui et al. (2000), the protein tyrosine kinase may be
the nonreceptor tyrosine kinase Fer. Disassembly of the
cadherin complex of proteins and the cytoskeletal connec-
tion on interaction of neurocan with its receptor may also
be accompanied by loss of cadherin dimers, which is the
functional unit required for strong adhesion (Yap et al.,
1997; Takeda et al., 1999).
Our data are consistent with inhibition of integrin func-
tion by neurocan being dependent on a signal generated
through cadherin. We base this on three lines of evidence.
First, we demonstrate that the interaction of neurocan
with the GalNAcPTase results in translocation of Fer from
its association with the cytoplasmic domain of cadherin
(Kim and Wong, 1995; Rosato et al., 1998) to the integrin
complex of proteins. This is consistent with the fact that
overexpression of Fer inhibits integrin-mediated adhesion
(Rosato et al., 1998). Additionally, we have shown (Ar-
regui et al., 2000) that inducing the release of Fer from the
Figure 14. Amacrine cells ex-
press neurocan. E9 retina
cells were cultured overnight
before staining with antibod-
ies. A shows the morphology
of typical cells expressing
neurocan. (B) Cells were
double stained with antisyn-
taxin and antineurocan. Bar,
20 mm.
Figure 15. Typical ganglion cells are not reactive
with antineurocan antibody. E9 cells cultured
overnight were stained with antineurocan and
8D9, a ganglion cell marker, followed by FITC-
conjugated secondary antibody. The arrowheads
point to cells showing typical ganglion cell mor-
phology, reactive with 8D9, but not antineuro-
can. The arrows point to cells reactive with both
antibodies, but with atypical ganglion cell mor-
phology. Bar, 20 mm.Li et al. Coordinate Regulation of Cadherin and Integrin by Neurocan 1285
cadherin complex using a cell permeable peptide contain-
ing a sequence mimicking the juxtamembrane region of
cadherin results in its translocation to the integrin complex
and loss of integrin function. Second, release of a complex
of proteins containing b-catenin, p120CAT, and Fer from
the cytoplasmic domain of cadherin before treatment of
cells with neurocan abolishes the effect of neurocan on in-
tegrin function (this article and Arregui et al., 2000). This
suggests that a specific array of effectors must be associ-
ated with the cadherin complex for transduction of the
neurocan-induced signal regulating integrin function to
occur. Third, cadherins, N and E (Balsamo and Lilien,
1990; Bauer et al., 1992), but not b1-integrins (Lilien et al.,
1999) are intimately associated with the GPI-anchored,
neurocan receptor GalNAcPTase, suggesting that the neu-
rocan-induced signal is mediated by cadherin. There are a
number of GPI-linked proteins that act as coreceptors in
the sense that the signal is transduced through a trans-
membrane partner. Perhaps the most interesting, for our
purposes, is the association of the receptor tyrosine kinase
Ret with GPI-linked coreceptors. Ret has two extracellu-
lar cadherin-like repeats (Iwamoto et al., 1993) and associ-
ates with two GPI-linked coreceptors. Binding of the
ligand to its GPI-linked coreceptors activates Ret phos-
phorylation setting the appropriate signaling pathway in
motion (Jing et al., 1996; Treanor et al., 1996; Buj-Bello et
al., 1997; Klein et al., 1997).
Loss of integrin function, either through overexpression
of Fer (Rosato et al., 1998) or through perturbation with a
cell permeable peptide mimicking the juxtamembrane re-
gion of cadherin (Arregui et al., 2000) is correlated with
hypophosphorylation of p130cas, as is the inability to as-
semble focal adhesions (Nojima et al., 1995; Petch et al.,
1995; Vuori and Ruoslahti, 1995). p130cas interacts directly
with the tyrosine phosphatases PTP-PEST (Garton et al.,
1997) and PTP1B (Liu et al., 1996), as well as the tyrosine
kinase FAK (Polte and Hanks, 1995). It has been sug-
gested that these components compete with each other
to regulate the tyrosine phosphorylation of p130cas and,
therefore, assembly of focal adhesions (Garton et al.,
1997). Tyrosine-phosphorylated p130cas also interacts with
Crk (Matsuda and Kurata, 1996), and this interaction has
the potential to protect p130cas from dephosphorylation
(Birge et al., 1992). The most conservative explanation for
the hypophosphorylation of p130cas on interaction of Fer
with the integrin complex is that Fer affects one or more of
p130cas9 binding partners, PTP-PEST, PTP1B, FAK or
even Crk, altering their activity, or their interaction with
p130cas, changing the balance of phosphorylated tyrosine
residues and, thus, integrin function.
Neurocan’s Modular Organization Allows Interactions 
with Many Adhesion-related Molecules
Neurocan is a member of a family of structurally similar
chondroitin sulfate proteoglycans (Margolis and Margolis,
1994) including aggrecan (Doege et al., 1987), versican
(Zimmermann and Ruoslahti, 1989), and brevican (Ya-
mada et al., 1994; Jaworski et al., 1995). The family has
been referred to as lecticans (Ruoslahti, 1996) or hyalec-
tans (Iozzo, 1998). All members of the family have a simi-
lar modular organization, a conserved Ig-loop and hyalu-
ronic acid (HA)–binding motifs at the NH2 terminus, and
EGF-like, lectin-like and complement regulatory-like do-
mains on the COOH terminus. The structure of this family
appears as two globular domains separated by a linear do-
main containing the majority of the chondroitin sulfate
chains (Retzler et al., 1996b).
Sequence comparisons of neurocan from rat (Rauch et
al., 1992), mouse (Rauch et al., 1995), human (Prange et
al., 1998), and now chicken, reveal that these NH2- and
COOH-terminal domains are highly conserved (Fig. 1 A).
However, the central elongate region shows little or no
conservation. These data suggest that each of the NH2-
and COOH-terminal domains has specific functions, while
the functional role(s) of the central portion requires only
conservation of minimal sequence motifs essential for gly-
cosylation.
Both the sugar side chains and the polypeptide back-
bone of neurocan interact with adhesion-related mol-
ecules. NCAM and NgCAM interact with neurocan
through the chondroitin sulfate chains (Friedlander et al.,
1994) and both intact neurocan and neurocan-C, a natu-
rally occurring COOH-terminal fragment with a 150-kD
core protein (Oohira et al., 1994), are able to inhibit ho-
mophilic binding of NCAM (Retzler et al., 1996a). Addi-
tionally, neurocan inhibits neurite extension by neurons
that express NCAM and NgCAM, presumably by interact-
ing directly with these cell adhesion molecules to disrupt
homophilic interactions (Grumet et al., 1993, 1996; Fried-
Figure 16. Pictorial representation of the known
protein interactions in the cadherin and integrin
complex potentially altered on binding of neuro-
can to its receptor GalNAcPTase. On the right
is a functional cadherin complex showing the
known protein interactions. The interaction of
b-catenin, p120ctn, and Fer is based on Arregui et
al. (2000). On the left, after binding of neurocan,
are the alterations induced in the cadherin com-
plex rendering it nonfunctional and potential Fer
targets in the integrin complex.The Journal of Cell Biology, Volume 149, 2000 1286
lander et al., 1994). In contrast, the Ig superfamily adhe-
sion molecule TAG-1/axonin-1 interacts with the neuro-
can core protein (Milev et al., 1996). The physiological
significance of these interactions is supported by the over-
lapping distribution of these adhesion molecules with neu-
rocan in embryonic and early postnatal nervous tissue
(Milev et al., 1996). 
The COOH terminus of the neurocan polypeptide in-
teracts with the extracellular matrix protein tenascin-C
(Rauch, 1997). The COOH-terminal lectinlike domain of
brevican binds cell-surface glycolipids and promotes cell
adhesion (Miura et al., 1999), suggesting a similar function
for the neurocan lectinlike domain. Additionally, the
COOH terminus of several family members can bind sim-
ple sugars (Halberg et al., 1988; Saleque et al., 1993; Ujita
et al., 1994), suggesting lectin-like interactions.
Our data add to the group of adhesion-related mole-
cules that interact with neurocan and further indicate a
specific role for the NH2 terminus containing the Ig loop
and the HA-binding domain in regulating cadherin and in-
tegrin function. The predominant expression of neurocan
in the central nervous system (Oohira et al., 1994; Meyer-
Puttlitz et al., 1995; Fukuda et al., 1997; Matsui et al., 1998)
and its multiple interactions through distinct domains with
adhesion-related molecules suggests that neurocan has
evolved as an modular extracellular regulator of cell–cell
and cell–matrix interactions that guide the cellular rear-
rangements essential to the formation and function of the
nervous system.
Neurocan May Act as a Barrier to Neurite Extension in 
the Developing Retina
In the developing retina, neurocan expression predomi-
nates in the IPL, but is also transiently associated with the
outer plexiform layer (OPL), whereas the GalNAcPTase,
which was originally distributed to most layers in the ret-
ina, becomes restricted to the ganglion cell layer and inner
nuclear layer, sandwiching the IPL. Consistent with this
distribution, we find that, in vitro, it is amacrine cells with
multiple processes that express and synthesize neurocan
and deposit it on the substrate around cell bodies and pro-
cesses.
There are two possible exceptions to this cellular distri-
bution. First, we occasionally observe that neurocan and
the amacrine cell marker HPC-1 do not overlap. This may
be explained by the number of different subtypes of ama-
crine cells, some expressing neurocan and others not,
but all being HPC-1–positive. Alternatively, HPC-1 also
weakly reacts with some horizontal cells (Gleason et al.,
1993), and it is possible that, in our culture system, some
HPC-1–positive cells are horizontal cells, not expressing
neurocan. We do observe transient neurocan staining in
the OPL at around day 14, and this may be due to tran-
sient expression by horizontal cells. Second, some neuro-
can-positive cells with typical stellate morphology are pos-
itive for the ganglion cell marker, 8D9. It is likely that
these cells are not ganglion cells. In fact, it has been shown
that 8D9 does stain the IPL faintly. This may be due to ei-
ther ganglion cell dendrites or processes of amacrine cells
(Lemmon and McLoon, 1986). Our finding that amacrine
cells express neurocan favors the latter possibility; how-
ever, we cannot exclude the possibility that some ganglion
cells may also express neurocan.
The ability of neurocan to affect the function of many
distinct adhesion molecules either directly or indirectly
suggests that its spatiotemporal distribution may play criti-
cal roles in morphogenesis of the retina. While much is
known about the distribution of adhesion molecules in the
developing retina and some functional analyses have been
performed using antibodies (Buskirk et al., 1980; Hoffman
et al., 1986; Matsununga et al., 1988; Svennevik and Linser,
1993; Stone and Sakaguchi, 1996) and by introducing dom-
inant negative constructs into the developing Xenopus eye
(Lilienbaum et al., 1995; Riehl et al., 1996), the role of en-
dogenous modifiers of adhesion molecule function, such as
neurocan, has not been explored experimentally. Chon-
droitin sulfate proteoglycans have been shown to act as a
barrier to neurite extension in general (Faissner and Stein-
dler, 1995; Margolis and Margolis, 1997) and have been
suggested to influence the direction of retinal ganglion cell
outgrowth (Snow et al., 1991). The expression of neurocan
juxtaposed by its receptor, GalNAcPTase, does indeed
suggest a role for this interacting pair in restricting cell or
process movement mediated by cadherin and/or integrin
at such boundaries. Furthermore, because of its interac-
tions with other adhesion molecules in the immunoglobu-
lin superfamily, neurocan is well suited to such a role in
the retina. Thus neurocan, and possibly other chondroitin
sulfate proteoglycans, may act to prevent ganglion cell
projections from extending to other layers of the retina,
orienting them to form the nerve fiber layer. Indeed, reti-
nal neurons extend processes in vitro mediated by cad-
herin, integrin and NCAM (Neugebauer et al., 1988), and
purified neurocan acts as barrier to neurite extension by
retina neurons in vitro (Balsamo et al., 1996).
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